These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 35933897)

  • 1. Shilajit extract reduces oxidative stress, inflammation, and bone loss to dose-dependently preserve bone mineral density in postmenopausal women with osteopenia: A randomized, double-blind, placebo-controlled trial.
    Pingali U; Nutalapati C
    Phytomedicine; 2022 Oct; 105():154334. PubMed ID: 35933897
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effect of Cissus quadrangularis L. on delaying bone loss in postmenopausal women with osteopenia: A randomized placebo-controlled trial.
    Benjawan S; Nimitphong H; Tragulpiankit P; Musigavong O; Prathanturarug S; Pathomwichaiwat T
    Phytomedicine; 2022 Jul; 101():154115. PubMed ID: 35523116
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of low-dose alendronate treatment on bone mineral density and bone turnover markers in Chinese postmenopausal women with osteopenia and osteoporosis.
    Li M; Zhang ZL; Liao EY; Chen DC; Liu J; Tao TZ; Wu W; Xia WB; Lu YJ; Sheng ZF; Lu CY; Meng GL; Xu L; Zhang WJ; Hu YY; Xu L
    Menopause; 2013 Jan; 20(1):72-8. PubMed ID: 22968256
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Combined bioavailable isoflavones and probiotics improve bone status and estrogen metabolism in postmenopausal osteopenic women: a randomized controlled trial.
    Lambert MNT; Thybo CB; Lykkeboe S; Rasmussen LM; Frette X; Christensen LP; Jeppesen PB
    Am J Clin Nutr; 2017 Sep; 106(3):909-920. PubMed ID: 28768651
    [No Abstract]   [Full Text] [Related]  

  • 5. Tocotrienol supplementation suppressed bone resorption and oxidative stress in postmenopausal osteopenic women: a 12-week randomized double-blinded placebo-controlled trial.
    Shen CL; Yang S; Tomison MD; Romero AW; Felton CK; Mo H
    Osteoporos Int; 2018 Apr; 29(4):881-891. PubMed ID: 29330573
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vitamin K supplementation in postmenopausal women with osteopenia (ECKO trial): a randomized controlled trial.
    Cheung AM; Tile L; Lee Y; Tomlinson G; Hawker G; Scher J; Hu H; Vieth R; Thompson L; Jamal S; Josse R
    PLoS Med; 2008 Oct; 5(10):e196. PubMed ID: 18922041
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of a Hop Extract Standardized in 8-Prenylnaringenin on Bone Health and Gut Microbiome in Postmenopausal Women with Osteopenia: A One-Year Randomized, Double-Blind, Placebo-Controlled Trial.
    Lecomte M; Tomassi D; Rizzoli R; Tenon M; Berton T; Harney S; Fança-Berthon P
    Nutrients; 2023 Jun; 15(12):. PubMed ID: 37375599
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effect of vitamin MK-7 on bone mineral density and microarchitecture in postmenopausal women with osteopenia, a 3-year randomized, placebo-controlled clinical trial.
    Rønn SH; Harsløf T; Oei L; Pedersen SB; Langdahl BL
    Osteoporos Int; 2021 Jan; 32(1):185-191. PubMed ID: 33030563
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oligopin® Supplementation Mitigates Oxidative Stress in Postmenopausal Women with Osteopenia: A Randomized, Double-blind, Placebo-Controlled Trial.
    Majidi Z; Ansari M; Maghbooli Z; Ghasemi A; Ebrahimi SSS; Hossein-Nezhad A; Emamgholipour S
    Phytomedicine; 2021 Jan; 81():153417. PubMed ID: 33250314
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Abaloparatide dose-dependently increases bone mineral density in postmenopausal women with osteoporosis: a phase 2 study.
    Matsumoto T; Sone T; Yamashita A; Inoue T
    J Bone Miner Metab; 2023 Nov; 41(6):807-816. PubMed ID: 37505256
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of a Multispecies Probiotic Supplement on Bone Health in Osteopenic Postmenopausal Women: A Randomized, Double-blind, Controlled Trial.
    Jafarnejad S; Djafarian K; Fazeli MR; Yekaninejad MS; Rostamian A; Keshavarz SA
    J Am Coll Nutr; 2017; 36(7):497-506. PubMed ID: 28628374
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Romosozumab increases bone mineral density in postmenopausal Japanese women with osteoporosis: A phase 2 study.
    Ishibashi H; Crittenden DB; Miyauchi A; Libanati C; Maddox J; Fan M; Chen L; Grauer A
    Bone; 2017 Oct; 103():209-215. PubMed ID: 28687496
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Twelve-month consumption of a polyphenol extract from olive (Olea europaea) in a double blind, randomized trial increases serum total osteocalcin levels and improves serum lipid profiles in postmenopausal women with osteopenia.
    Filip R; Possemiers S; Heyerick A; Pinheiro I; Raszewski G; Davicco MJ; Coxam V
    J Nutr Health Aging; 2015 Jan; 19(1):77-86. PubMed ID: 25560820
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevention of bone loss by clodronate in early postmenopausal women with vertebral osteopenia: a dose-finding study.
    Välimäki MJ; Laitinen K; Patronen A; Puolijoki H; Seppänen J; Pylkkänen L; Aranko SM; Sairanen S; Blåfield H; Rekiaro M; Väisänen K; Kormano M; Mäkinen L; Salmi J; Ala-Kaila K; Perttilä J; Vesterinen K; Koivunoro K;
    Osteoporos Int; 2002 Dec; 13(12):937-47. PubMed ID: 12459936
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The relationship of biochemical markers of bone turnover to bone density changes in postmenopausal women: results from the Postmenopausal Estrogen/Progestin Interventions (PEPI) trial.
    Marcus R; Holloway L; Wells B; Greendale G; James MK; Wasilauskas C; Kelaghan J
    J Bone Miner Res; 1999 Sep; 14(9):1583-95. PubMed ID: 10469288
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevention of osteoporosis and uterine effects in postmenopausal women taking raloxifene for 5 years.
    Jolly EE; Bjarnason NH; Neven P; Plouffe L; Johnston CC; Watts SD; Arnaud CD; Mason TM; Crans G; Akers R; Draper MW
    Menopause; 2003; 10(4):337-44. PubMed ID: 12851517
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of Multispecies Probiotic Supplementation on Serum Bone Turnover Markers in Postmenopausal Women with Osteopenia: A Randomized, Double-Blind, Placebo-Controlled Trial.
    Vanitchanont M; Vallibhakara SA; Sophonsritsuk A; Vallibhakara O
    Nutrients; 2024 Feb; 16(3):. PubMed ID: 38337745
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oral daily ibandronate prevents bone loss in early postmenopausal women without osteoporosis.
    McClung MR; Wasnich RD; Recker R; Cauley JA; Chesnut CH; Ensrud KE; Burdeska A; Mills T;
    J Bone Miner Res; 2004 Jan; 19(1):11-8. PubMed ID: 14753731
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antiosteoporotic Activity of Genistein Aglycone in Postmenopausal Women: Evidence from a Post-Hoc Analysis of a Multicenter Randomized Controlled Trial.
    Arcoraci V; Atteritano M; Squadrito F; D'Anna R; Marini H; Santoro D; Minutoli L; Messina S; Altavilla D; Bitto A
    Nutrients; 2017 Feb; 9(2):. PubMed ID: 28241420
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Relationships among serum receptor of nuclear factor-kappaB ligand, osteoprotegerin, high-sensitivity C-reactive protein, and bone mineral density in postmenopausal women: osteoimmunity versus osteoinflammatory.
    Nabipour I; Larijani B; Vahdat K; Assadi M; Jafari SM; Ahmadi E; Movahed A; Moradhaseli F; Sanjdideh Z; Obeidi N; Amiri Z
    Menopause; 2009; 16(5):950-5. PubMed ID: 19387415
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.